{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:37:00Z","timestamp":1787683020452,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejmech.2020.112219","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T03:07:53Z","timestamp":1583809673000},"page":"112219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes"],"prefix":"10.1016","volume":"193","author":[{"given":"Vikas","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112219_bib1","author":"World Health Organization"},{"key":"10.1016\/j.ejmech.2020.112219_bib2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2020.112219_bib3","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1080\/14756366.2019.1670657","article-title":"Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones","volume":"34","author":"Bilginer","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib4","doi-asserted-by":"crossref","first-page":"103057","DOI":"10.1016\/j.bioorg.2019.103057","article-title":"New phenolic Mannich bases with piperazines and their bioactivities","volume":"90","author":"Gul","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib5","doi-asserted-by":"crossref","first-page":"103095","DOI":"10.1016\/j.bioorg.2019.103095","article-title":"Synthesis and biological evaluation of some new mono Mannich bases with piperazines as possible anticancer agents and carbonic anhydrase inhibitors","volume":"90","author":"Tugrak","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/14756366.2019.1700240","article-title":"Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties","volume":"35","author":"Bilginer","year":"2020","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib7","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.bmc.2009.01.067","article-title":"Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols","volume":"17","author":"\u015eent\u00fcrk","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1747-0285.2010.00965.x","article-title":"Carbonic anhydrase inhibitors: inhibition of human erythrocyte isozymes I and II with a series of phenolic acids","volume":"75","author":"Sarikaya","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112219_bib9","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/acsmedchemlett.8b00334","article-title":"Famotidine, an antiulcer agent, strongly inhibits Helicobacter pylori and human carbonic anhydrases","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112219_bib10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2014.02.023","article-title":"4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII","volume":"76","author":"Khloya","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bioorg.2019.03.003","article-title":"Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma","volume":"87","author":"Kurt","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib12","doi-asserted-by":"crossref","first-page":"103130","DOI":"10.1016\/j.bioorg.2019.103130","article-title":"Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors","volume":"91","author":"Chiaramonte","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib13","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1080\/14756366.2019.1664501","article-title":"Activation of alpha-, beta-, gamma- delta-, zeta- and eta- class of carbonic anhydrases with amines and amino acids: a review","volume":"34","author":"Akocak","year":"2019","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib14","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2020.112219_bib15","doi-asserted-by":"crossref","first-page":"10103","DOI":"10.3390\/molecules190710103","article-title":"Capsaicin: a potent inhibitor of carbonic anhydrase isoenzymes","volume":"19","author":"Arabaci","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112219_bib16","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1016\/j.bmc.2015.04.019","article-title":"Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: novel sulfamoylcarbamates and sulfamides derived from acetophenones","volume":"23","author":"Ak\u0131nc\u0131o\u011flu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib17","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.bmc.2014.12.054","article-title":"N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II","volume":"23","author":"Y\u0131ld\u0131r\u0131m","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm501573b","article-title":"Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties","volume":"58","author":"Bozta\u015f","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112219_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138161208783877884","article-title":"Carbonic anhydrases an overview","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2020.112219_bib21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112219_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: an update","volume":"7","author":"Supuran","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib25","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Can. Res."},{"key":"10.1016\/j.ejmech.2020.112219_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bioorg.2018.10.042","article-title":"Synthesis of 1,2,4-triazole-5-on derivatives and determination of carbonic anhydrase II isoenzyme inhibition effects","volume":"83","author":"Akin","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib27","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1021\/acs.jmedchem.8b01504","article-title":"4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides selectively target the tumor-associated carbonic anhydrase isoforms IX and XII showing hypoxia-enhanced antiproliferative profiles","volume":"61","author":"Nocentini","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2019.06.081","article-title":"Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic\/phobic tails for targeting the middle region of human carbonic anhydrases active site: selective inhibitors of hCA IX","volume":"179","author":"Allam","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib29","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.04.016","article-title":"Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: selective inhibitors for the tumor-associated hCA IX isoform","volume":"152","author":"Ibrahim","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib31","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.bmcl.2015.02.069","article-title":"Synthesis and antiviral activity of 2-substituted methylthio-5-(4-amino-2-methylpyrimidin-5-yl)-1,3,4-oxadiazole derivatives","volume":"25","author":"Wu","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112219_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/1871523014666150820100212","article-title":"Synthesis, characterization and screening for analgesic and anti-inflammatory activities of 2, 5-disubstituted 1, 3, 4-oxadiazole derivatives","volume":"14","author":"Dewangan","year":"2015","journal-title":"Antiinflamm. Antiallergy Agents Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib33","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1016\/j.ejmech.2010.08.039","article-title":"Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives","volume":"45","author":"Manjunatha","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2015.06.020","article-title":"Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents","volume":"101","author":"Banerjee","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib35","first-page":"1344","article-title":"Tubulin-dependent hydrolysis of guanosine triphosphate as a screening test to identify new antitubulin compounds with potential as antimitotic agents: application to carbamates of aromatic amines","volume":"49","author":"Chi","year":"1989","journal-title":"Can. Res."},{"key":"10.1016\/j.ejmech.2020.112219_bib36","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bmc.2013.12.043","article-title":"Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents","volume":"22","author":"Shahzad","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib37","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1021\/jm500303u","article-title":"1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells","volume":"57","author":"Valente","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib38","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/sj.bjc.6602676","article-title":"Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence","volume":"92","author":"Morris","year":"2005","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2020.112219_bib39","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.bmcl.2013.03.068","article-title":"Synthesis and antitumor activity of 1,3,4-oxadiazole possessing 1,4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors","volume":"23","author":"Sun","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112219_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejmech.2019.01.001","article-title":"Synthesis and anticancer evaluation of new lipophilic 1,2,4 and 1,3,4-oxadiazoles","volume":"165","author":"Caneschi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.03.030","article-title":"Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors","volume":"150","author":"Vats","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bioorg.2019.01.002","article-title":"Synthesis of novel benzenesulfonamide bearing 1,2,3-triazole linked hydroxy-trifluoromethylpyrazolines and hydrazones as selective carbonic anhydrase isoforms IX and XII inhibitors","volume":"85","author":"Sharma","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib43","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejmech.2018.06.021","article-title":"Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors","volume":"155","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib44","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/14756366.2017.1367775","article-title":"Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity","volume":"32","author":"Kumar","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib45","doi-asserted-by":"crossref","first-page":"111698","DOI":"10.1016\/j.ejmech.2019.111698","article-title":"Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors","volume":"183","author":"Vats","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib46","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bmc.2016.12.047","article-title":"Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors","volume":"25","author":"Kumar","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.03.075","article-title":"Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors","volume":"81","author":"Guo","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mrc.1270100135","article-title":"NMR studies of the keto\u2013enol tautomerism of acylthioacetamides","volume":"10","author":"Klose","year":"1977","journal-title":"Org. Magn. Reson."},{"key":"10.1016\/j.ejmech.2020.112219_bib49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1039\/C4OB02155J","article-title":"6-Substituted 1,2-benzoxathiine-2,2-dioxides are isoform-selective inhibitors of human carbonic anhydrases IX, XII and VA","volume":"13","author":"Tanc","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2020.112219_bib50","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420301860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420301860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:10:35Z","timestamp":1759327835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420301860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":50,"alternative-id":["S0223523420301860"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112219","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112219"}}